Drum roll, please. The PIDS/IDSA Clinical Practice Guidelines on the Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics were published in JPIDS this week. I want to acknowledge all…
Please consider this rewarding opportunity! The PIDS Editor Selection Subcommittee of the Publications Committee seeks applications for the next Editor-in-Chief of the Journal of the Pediatric Infectious Diseases Society. Dr….
PIDS recently announced its strong support of universal masking for all school staff and students 2 years of age and older, as well as vaccination against COVID-19 for all eligible, in line…
A new clinical practice guideline issued by the American Academy of Pediatrics addresses questions related to evaluating otherwise well-appearing infants between 8-60 days old who develop a fever. The guideline…
David Hyun, MD, is the director of the Antibiotic Resistance Project at The Pew Charitable Trusts, a non-profit, non-partisan policy research organization. The Antibiotic Resistance Project conducts research and advocacy…
PIDS has extended the deadline for the research funding opportunity for fellows and junior faculty who identify as underrepresented in medicine (UIM) to October 8, 2021. Additional details on this opportunity…
This was a week for celebration. Across the United States, new pediatric infectious diseases fellows began their training. Please join me in extending a warm welcome to the newest members…
Fully updated for COVID-19 and accessible on Android devices for the first time, the latest version of the Vaccine Handbook App, a comprehensive, practical resource for information about vaccination and…
At its recent meeting, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted unanimously to recommend use of a three-dose dengue vaccine for children 9 to…
Update on Myocarditis Following COVID-19 Immunization PIDS On Call is a new initiative of PIDS that uses a webinar-based format to bring important clinical issues within pediatric infectious diseases to PIDS…
A dengue vaccine candidate had 62.0% efficacy against the illness and 83.6% efficacy against hospitalized dengue in children and adolescents, according to recently reported trial results. The data comes from…
Two recent reports highlighted the concerning drop in routine child and adolescent vaccinations during the pandemic and the risk of outbreaks of vaccine-preventable diseases. An analysis of immunization information systems…
Improving the health of children worldwide through philanthropic support of scientific and educational programs.
